Why is RGEN Down Today?
About Repligen Corp
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers i...
Overall Confidence: 67%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
NORMAL - This move is backed by significant volume and appears sustainable.
📍 Sector Context
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector: -1.7%
Market Comparison
Quick Trade Ideas
Options strategies to consider for RGEN's -6% move
No Options Available
RGEN doesn't have listed options or options data is currently unavailable.
Try another stock in our Options Calculator →🔔 Get RGEN Alerts
We'll notify you when RGEN's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
RGEN has moved more than 3.0% down on 28 occasions in the past year.
Frequently Asked Questions
Why is RGEN stock down today?
This appears to be a sector-wide move. The BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector is down 1.7% on average.
Is RGEN stock a buy or sell right now?
Based on current analysis, RGEN shows 67% confidence in today's move. Volume is moderate which supports the trend. View full buy/sell analysis →
What is the RGEN stock price target?
RGEN is currently trading at $180.37. Based on today's momentum, the expected short-term range is $174.96 - $183.98. See long-term price prediction →
Will RGEN stock continue falling?
Our analysis shows a 45% probability that RGEN's move continues in the next 1-3 days. Key level to watch: $171.35 (support).
Is RGEN stock oversold or overbought?
RGEN's RSI (Relative Strength Index) is currently at 51.8. This shows bullish momentum - the stock has positive momentum but isn't overextended yet.
What is the momentum for RGEN stock?
RGEN's 10-day momentum indicator is at 2.18. Strong bullish momentum - the stock is gaining significant upward force. This often precedes continued gains.
Is RGEN outperforming or underperforming the market?
RGEN (-6.17%) is currently significantly underperforming the market (-6.3% vs SPY). Today, the S&P 500 (SPY) is up 0.18%, and Nasdaq (QQQ) is up 0.31%.
What does MACD indicate for RGEN?
RGEN's MACD (5.92) is currently above the signal line (5.51), indicating a bullish trend. This technical signal suggests buying pressure is dominant. The trend strength (ADX: 40.9) is strong.
Is RGEN in an uptrend or downtrend?
Based on moving average analysis, RGEN is in a bullish trend. The price ($180.37) is trading above both the 20-day SMA ($178.25) and 50-day SMA ($168.85). This alignment typically indicates sustained upward momentum.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis